Related Experiment Videos
Sandwich immunoassay for intact human osteocalcin
K Hosoda1, H Eguchi, T Nakamoto
1Institute for Biomedical Research, Teijin Ltd., Tokyo, Japan.
Clinical Chemistry
|November 1, 1992
Summary
A new sandwich enzyme immunoassay (EIA) for intact human osteocalcin (hOC) offers superior specificity over radioimmunoassay (RIA). This enhanced method shows potential for improved diagnostics in conditions like renal failure.
Area of Science:
- Biochemistry
- Immunology
- Clinical Chemistry
Background:
- Conventional radioimmunoassay (RIA) for human osteocalcin (hOC) suffers from limited region specificity.
- Accurate measurement of intact hOC is crucial for diagnosing bone metabolism disorders.
Purpose of the Study:
- To develop a highly specific sandwich enzyme immunoassay (EIA) for intact human osteocalcin (hOC).
- To evaluate the region and species specificity of the developed EIA compared to conventional RIA.
Main Methods:
- Development of a sandwich enzyme immunoassay (EIA) using antibodies against N- and C-terminal regions of hOC.
- Analysis of tryptic digests of hOC and serum from renal failure patients using reversed-phase HPLC.
- Assessment of cross-reactivity with bovine and rat osteocalcins.
Main Results:
- The developed sandwich EIA demonstrated superior region specificity for intact hOC.
- Preliminary studies in renal failure patients showed lower positive rates with EIA than RIA, confirming specificity.
- The assay exhibited high species specificity, with minimal cross-reactivity to bovine and rat osteocalcins.
Conclusions:
- The novel sandwich EIA offers significantly improved specificity for intact hOC compared to conventional RIA.
- This enhanced specificity suggests potential for superior diagnostic accuracy in clinical applications, particularly in renal failure patients.